The current valuation score of Purple Biotech Ltd is 9.55, ranking 25 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.31, which is -8.34% below the recent high of -0.28 and -129533.10% above the recent low of -396.29.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.